Ian Clements, Chief Financial Officer at Mirum Pharmaceuticals, Inc. (MIRM), bought 1,592 shares at $18.65 ($30K) on 2020-12-23, disclosed to the SEC on 2021-03-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MIRM | BUY | 2020-12-28 | $46K | — | Filing → |
| MIRM | BUY | 2019-09-10 | $46K | — | Filing → |